Resolute Integrity™ RSINT35026UXRecalls & reported problems
Medtronic, Inc. · Stent RSINT35026UX MicroTrac 3.50X26RX · Class 3 · Implant
All models of Resolute Integrity (52)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169037144), received between Mar 24, 2017 and Aug 9, 2018 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Device Expiration Issue1
- Material Deformation1
Patient problems
- No Consequences Or Impact To Patient3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 9, 2018Material Deformation
DURING THE PROCEDURE, AN ATTEMPT WAS MADE TO USE ONE RESOLUTE INTEGRITY DRUG ELUTING STENT TO TREAT A LESION. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP. THE DEVICE WAS INSPECTED WITH NO ISSUES IDENTIFIED. NEGATIVE PREP WAS NOT PERFORMED. IT WAS REPORTED THAT THE STENT DEFORMATION OCCURRED IN VIVO DURING POSITIONING. PATIENT STATUS POST-PROCEDURE IS ALIVE WITH NO INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7766414 ↗MalfunctionSep 22, 2017Device Expiration Issue; Device Expiration Issue
IT WAS REPORTED THAT THE PHYSICIAN WAS ATTEMPTING TO USE A RESOLUTE INTEGRITY DRUG ELUTING STENT TO TREAT A LESION IN THE RCA. NO DAMAGE TO DEVICE PACKAGING AND NO ISSUES REMOVING DEVICE FROM HOOP/TRAY. DEVICE WAS INSPECTED AND NEGATIVE PREP PERFORMED WITH NO ISSUES NOTED. IT WAS REPORTED THAT THE STENT WAS IMPLANTED APPROXIMATELY 16 DAYS POST EXPIRY DATE. NO PATIENT INJURY OR MEDICAL/SURGICAL INTERVENTION REPORTED. THE PATIENT IS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6885689 ↗MalfunctionMar 24, 2017Detachment of Device or Device Component; Detachment of Device or Device Component
THE PHYSICIAN WAS TREATING THE MID LAD- DIAGONAL BRANCH. THE VESSEL HAD SEVERE CALCIFICATION, 90% STENOSIS AND SEVERE TORTUOSITY; ARTERY DIAMETER 3.5MM. THE PHYSICIAN IMPLANTED ONE RESOLUTE INTEGRITY 3.0 X 26MM DRUG-ELUTING STENT IN THE 3RD DIAGONAL VESSEL INTO THE LAD AT THE BIFURCATION. MULTIPLE BALLOONS WERE PASSED THROUGH THE STENT STRUTS TO PTA THE MID LAD. THEN MULTIPLE STENTS WERE ATTEMPTED TO BE PLACED IN THE LAD WHICH RESULTED IN 5 NO CROSSES. ONE OF THE DEVICES THAT DID NOT CROSS WAS A SECOND 3.5X26MM RESOLUTE INTEGRITY. DURING DELIVERY OF THE SECOND 3.5X26MM RESOLUTE INTEGRITY, RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE AND THE SHAFT BROKE. EXCESSIVE FORCE WAS USED DURING DELIVERY AND THE DEVICE DID PASS THROUGH THE PREVIOUSLY DEPLOYED STENT. THE SHAFT OF THE DEVICE SNAPPED IN HALF BUT WAS REMOVED FROM THE PATIENT USING NORMAL PROCEEDINGS. THEN A 3.5X20MM CHOCOLATE BALLOON CATHETER WAS PASSED THROUGH THE STENTS STRUTS TO PTA THE MID LAD. UPON REMOVAL OF THE CHOCOLATE BALLOON, ONE OF THE NITINOL WIRES THAT MAKE UP THE CAGE WAS CAUGHT IN THE FIRST 3.0 X 26MM STENT. IT WAS REPORTED THAT THIS CAUSED THE STENT TO FRACTURE, AND 2/3 OF THE STENT BECAME DISLODGED AND W
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6430880 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page